Executives
-
Robert B. FordChairman of the Board and Chief Executive Officer -
Robert E. Funck Jr.Executive Vice President -
Philip P. BoudreauSenior Vice President -
Hubert L. AllenExecutive Vice President -
Lisa D. EarnhardtExecutive Vice President and Group President -
Daniel G. SalvadoriExecutive Vice President and Group President -
Allen Hubert LEXECUTIVE VICE PRESIDENT -
Ford Robert BCHAIRMAN AND CEO
-
Boudreau Philip PEXECUTIVE VICE PRESIDENT
-
Mccoy John A. Jr.VICE PRESIDENT
-
Morrone Louis H.EXECUTIVE VICE PRESIDENT
-
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENT
-
Earnhardt Lisa DEXECUTIVE VICE PRESIDENT
-
Wainer Andrea FEXECUTIVE VICE PRESIDENT
-
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENT
-
Moreland Mary KEXECUTIVE VICE PRESIDENT
Board Directors
-
R. J. AlpernDirector
-
C. Babineaux-FontenotDirector
-
S. E. BlountDirector
-
P. GonzalezDirector
-
M. A. KumbierDirector
-
D. W. McDewDirector
-
N. McKinstryDirector
-
M. G. OGradyDirector
-
W. A. OsbornDirector
-
M. F. RomanDirector
-
D. J. StarksDirector
-
J. G. StrattonDirector
-
G. F. TiltonDirector
-
Stratton John GDirector
-
Roman Michael FDirector
-
Gonzalez Patricia PaolaDirector
-
Alpern Robert JDirector
-
Starks Daniel JDirector
-
O'Grady MichaelDirector
-
Mckinstry NancyDirector
-
Mcdew Darren WDirector
-
Kumbier MichelleDirector
-
Blount Sally E.Director
-
Babineaux-Fontenot ClaireDirector
?
Moreland Mary K
EXECUTIVE VICE PRESIDENT
Abbott Laboratories
US, North Chicago [HQ]
CIK
1783147
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
91,936
Price per Share :
$113.91
Equivalence :
$10,472,429.76
Transaction History
-
F91,936 Shares After TransactionValue : $11,036,916.80$703,733.10Transaction Date : 02/29/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
S91,260 Shares After TransactionValue : $10,814,310.00Sold $80,106.00Transaction Date : 03/01/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
A97,798 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/21/24
-
Footnotes
-
-
Footnotes:#1 These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.